Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma

Our small series has demonstrated encouraging oncologic efficacy for RPLND as a primary treatment of retroperitoneal lymph node-positive seminoma. A multi-institutional phase II trial of RPLND for stage IIA seminoma is being developed.